Clinical Trial Update: Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a flavored oral formulation of ondansetron for persistent vomiting in gastroenteritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Gastroenteritis | Phase 1 | Status: COMPLETED